(19)

(11)

EP 4 087 691 A1

(12)

(43) Date of publication: 16.11.2022 Bulletin 2022/46 (21) Application number: 21738256.3 (22) Date of filing: 07.01.2021

(51) International Patent Classification (IPC):  B09C 1/00(2006.01) B09C 1/08(2006.01) (52) Cooperative Patent Classification (CPC): B09C 1/08 (86) International application number: PCT/US2021/012540 (87) International publication number: WO 2021/142152 (15.07.2021 Gazette 2021/28)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 07.01.2020 US 202016736546 03.04.2020 US 202063004858 P 12.06.2020 US 202016900816 (71) Applicant: Armis Biopharma, Inc. Fort Collins, CO 80528 (US)	(72) Inventors: NOBLITT, Scott Fort Collins, CO 80525 (US) NEAS, Edwin Nunn, CO 80648 (US) (74) Representative: Barker Brettell LLP  100 Hagley Road Edgbaston Birmingham B16 8QQ Birmingham B16 8QQ (GB)